The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome

NCT02484924 · clinicaltrials.gov ↗

COMPLETED

Status

5225

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Coronary Syndrome
Bleeding
Novel Anti-platelets
Ticagrelor
Clopidogrel

Interventions

DRUG: Ticagrelor

Sponsor

Liverpool University Hospitals NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]